Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A randomized, single-blind, multi-center, Phase III clinical trial to evaluate the efficacy and safety of adhesion barrier Mediclore versus no treatment in patients with total thyroidectomy
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mediclore® | Experimental | adhesion barrier Mediclore 5cc, to apply medical device fully around thyroid gland following thyroidectomy |
|
| No treatment | No Intervention | No treatment, standard treatment for thyroidectomy |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mediclore® (adhesion barrier) | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Adhesion incidence rate following 8 weeks | 8 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wan Huh | Contact | +82-2-550-8106 | whuh408@daewoong.co.kr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ajou University Hospital | Recruiting | Suwon | Gyeonggi-do | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided